Ref ID: 19216
Author:
R. Ben-Ami*, I. Benhar, V. Dergachev, Y. Shadkchan, N. Osherov
Author address:
Aviv, IL
Full conference title:
23rd European Congress of Clinical Microbiology and
Infectious Diseases
Date: 27 April 2014
Abstract:
Objectives: Invasive aspergillosis (IA) is associated with poor outcomes in immunosuppressed hosts. Suppression of angiogenesis by the Aspergillus metabolite gliotoxin (GT) may facilitate tissue hypoxia and persistent infection. We hypothesized that GT-neutralizing antibodies (GTnAb) would restore angiogenic activity and promote fungal clearance and host survival.
Methods: We immunized BALB/c mice alternately with GT conjugated to bovine albumin and keyhole limpet hemocyanin. Successful conjugation was determined by Western blot and GT antiserum titer was determined by ELISA. The ability of antisera to neutralize GT activity was tested using a Matrigel angiogenesis assay. Lastly, we assessed treatment with GTnAb, alone and in combination with amphotericin B, in a murine model of IA using 2 immunosuppression regimens: cortisone alone (non-neutropenic model) and cyclophosphamide/cortisone (neutropenic model). Control mice were treated with pre-immune sera. Mortality and tissue fungal burden (qPCR) were compared among treatment arms.
Results: BALB/c mouse immunization resulted in high titers (>1:50,000) of GT-specific antibodies. Antisera reversed the in vitro antiangiogenic activities of GT and Aspergillus culture filtrates, indicating high titers of GTnAb. GTnAb significantly reduced the pulmonary fungal burden in non-neutropenic (P=0.0001), but not in neutropenic mice. Conversely, GTnAb significantly increased the survival rate of neutropenic mice (51% versus 23% for mice treated with pre-immune serum, P=0.04 by the logrank test), but not of non-neutropenic mice. There was no synergistic interaction between GTnAb and amphotericin B.
Conclusion: Our immunization strategy induced high titers of GTnAb in BALB/c mice. GTnAb had dissociated effects on fungal burden and survival rate in the murine IA models. Thus, GTnAb enhanced the survival rate of neutropenic mice without reducing tissue fungal burden, possibly through modulation of host angiogenesis and inflammatory response. These findings provide rationale for further efforts to produce GT monoclonal Abs
Abstract Number: P1087
Conference Year: 2013
Link to conference website: http://registration.akm.ch/einsicht.php?XNABSTRACT_ID=162748&XNSPRACHE_ID=2&XNKONGRESS_ID=180&XNMASK
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a